PE Consortium to Exit Chamberlin Edmonds

Charterhouse Group, Highlander Partners and MTS Health Investors have agreed to sell Chamberlin Edmonds & Associates to Emdeon (NYSE: EM) in a $260 million cash deal. The company provides patient eligibility and cost recovery services for hospitals and is being advised by Robert W. Baird and Bryan Cave, while Proskauer Rose is advising Charterhouse. The selling consortium acquired the company in a $100 million LBO in 2008. Emdeon also has PE backers, including General Atlantic and Hellman & Friedman.